We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$387M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$332M
3
NOW icon
ServiceNow
NOW
+$265M
4
NYT icon
New York Times
NYT
+$189M
5
MXIM
Maxim Integrated Products
MXIM
+$152M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$456M
2
IPHI
INPHI CORPORATION
IPHI
+$311M
3
IQV icon
IQVIA
IQV
+$278M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$277M
5
EDU icon
New Oriental
EDU
+$192M

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
26
DELISTED
Acceleron Pharma
XLRN
$314M 1.28%
2,500,000
-100,000
-4% -$12.6M
CHTR icon
27
Charter Communications
CHTR
$17.9B
$307M 1.25%
425,901
-28,277
-6% -$19M
TRU icon
28
TransUnion
TRU
$16.2B
$306M 1.25%
2,782,782
-377,295
-12% -$39.3M
V icon
29
Visa
V
$693B
$292M 1.19%
1,249,404
-59,425
-5% -$13.6M
NYT icon
30
New York Times
NYT
$10.6B
$288M 1.18%
6,615,258
+4,235,636
+178% +$189M
NOW icon
31
ServiceNow
NOW
$133B
$287M 1.17%
+2,610,000
New +$265M
SHW icon
32
Sherwin-Williams
SHW
$84.1B
$285M 1.16%
1,045,168
-140,255
-12% -$38.4M
BX icon
33
Blackstone
BX
$108B
$284M 1.16%
2,921,736
-1,509,385
-34% -$134M
HLT icon
34
Hilton Worldwide
HLT
$73.5B
$277M 1.13%
2,300,077
+350,640
+18% +$43.8M
ELV icon
35
Elevance Health
ELV
$86.9B
$248M 1.01%
650,000
-175,000
-21% -$66.9M
AMRS
36
DELISTED
Amyris Inc.
AMRS
$215M 0.88%
13,110,000
-390,000
-3% -$5.82M
EXEL icon
37
Exelixis
EXEL
$13.4B
$200M 0.82%
11,000,000
+250,000
+2% +$5.83M
BEAM icon
38
Beam Therapeutics
BEAM
$3.07B
$193M 0.79%
1,500,000
+907,519
+153% +$72.3M
FATE icon
39
Fate Therapeutics
FATE
$279M
$165M 0.68%
1,905,000
+5,000
+0.3% +$403K
HWM icon
40
Howmet Aerospace
HWM
$108B
$162M 0.66%
4,702,479
+1,746,750
+59% +$58.3M
ALNY icon
41
Alnylam Pharmaceuticals
ALNY
$31.6B
$161M 0.66%
950,000
+250,000
+36% +$36.6M
BABA icon
42
Alibaba
BABA
$286B
$153M 0.63%
676,400
– –
SJR
43
DELISTED
Shaw Communications Inc.
SJR
$146M 0.6%
+5,045,000
New +$146M
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$145M 0.59%
900,000
+50,000
+6% +$8.03M
KSU
45
DELISTED
Kansas City Southern
KSU
$138M 0.56%
486,000
+246,000
+103% +$71M
IOVA icon
46
Iovance Biotherapeutics
IOVA
$3.76B
$137M 0.56%
5,250,000
+500,000
+11% +$13M
LU icon
47
Lufax Holding
LU
$1.2B
$128M 0.52%
2,831,100
+372,750
+15% +$18.8M
EFX icon
48
Equifax
EFX
$22.6B
$121M 0.49%
503,384
-103,245
-17% -$23.1M
COHR
49
DELISTED
Coherent Inc
COHR
$111M 0.45%
420,000
+295,000
+236% +$77.6M
QGEN icon
50
Qiagen
QGEN
$9.1B
$108M 0.44%
2,111,853
-282,021
-12% -$14.6M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.